Clinical Trial

Use of the Neurolyser XR for the Treatment of Low Back Pain Related to Sacroiliitis

Recruiting
View on ClinicalTrials.gov →
Summary
The Neurolyser XR is a device used to deliver high-intensity focused ultrasound for the ablation of the lateral sacral branch nerve in patients with Sacroiliitis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-09-21; most recent amendment 2025-05-19.
Status change: Not Yet Recruiting → Recruiting 2025-05-19
Trial Details
NCT Number NCT06053255
Lead Sponsor FUSMobile Inc.
Collaborators: Focused Ultrasound Foundation
Conditions Sacroiliitis
Enrollment 10 participants
Start Date 2024-09-13
Primary Completion 2026-09-15 (estimated)
Study Completion 2026-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-05-22